Status:
COMPLETED
A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world Settings
Lead Sponsor:
Pfizer
Conditions:
Severe Alopecia Areata
Eligibility:
All Genders
18+ years
Brief Summary
This study is a secondary analysis of the Adelphi Real World Alopecia Areata II United States Disease Specific Programmes database. This database contains data from a cross-sectional study capturing l...
Eligibility Criteria
Inclusion
- Aged 18 years or older with severe alopecia areata
Exclusion
Key Trial Info
Start Date :
February 3 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 30 2025
Estimated Enrollment :
123 Patients enrolled
Trial Details
Trial ID
NCT07200128
Start Date
February 3 2025
End Date
May 30 2025
Last Update
September 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer
New York, New York, United States, 10001